COLOMBO, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 856
NA - Nord America 655
AS - Asia 367
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 1.883
Nazione #
US - Stati Uniti d'America 646
SE - Svezia 515
SG - Singapore 216
RU - Federazione Russa 175
CN - Cina 108
IT - Italia 76
FI - Finlandia 23
IE - Irlanda 23
DE - Germania 16
GB - Regno Unito 15
IR - Iran 10
JP - Giappone 9
CA - Canada 6
HK - Hong Kong 6
IN - India 6
PK - Pakistan 5
EU - Europa 4
FR - Francia 4
MX - Messico 3
NL - Olanda 3
DK - Danimarca 2
ES - Italia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AT - Austria 1
CZ - Repubblica Ceca 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 1.883
Città #
Lawrence 191
Princeton 191
Singapore 109
Moscow 105
Shanghai 91
Ashburn 49
New York 35
Milan 28
Boardman 25
Dublin 22
Helsinki 20
Durham 6
Rome 6
Bari 4
Genoa 4
Islington 4
Khanewal 4
Kobe 4
Springfield 4
Edinburgh 3
Lappeenranta 3
Los Angeles 3
Monterrey 3
Naaldwijk 3
Seattle 3
Bethesda 2
Borås 2
Central 2
Copenhagen 2
Delhi 2
Gourock 2
Hamburg 2
Hong Kong 2
Jeddah 2
Madrid 2
Monza 2
Mountain View 2
Phuket 2
Pistoia 2
Pulandian 2
Pune 2
Redwood City 2
Romainville 2
Sesto San Giovanni 2
Tokyo 2
Torre del Lago Puccini 2
Toshima 2
Vadodara 2
Vancouver 2
Washington 2
Arezzo 1
Beijing 1
Bulgorello 1
Castiglione D'adda 1
Cheyenne 1
Chivasso 1
Cork 1
Dalsjoefors 1
Earls Court 1
Gouesnou 1
Hanover 1
Istanbul 1
Kashan 1
Kish 1
Leawood 1
Makati City 1
Modena 1
Montechiarugolo 1
Montevideo 1
Montreal 1
Napoli 1
Quetta 1
Redondo Beach 1
Rende 1
Riverside 1
San Francisco 1
San Zeno Naviglio 1
Taipei 1
Tehran 1
Toyonaka 1
Vienna 1
Totale 1.001
Nome #
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 26
Prognostic impact of mitral regurgitation changes after TAVI 25
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 25
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 24
Diabetes and mortality in patients with COVID-19: Are we missing the link? 23
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 22
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 22
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 22
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 21
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 21
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 20
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 19
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 19
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 19
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 18
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 18
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 18
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 18
[New therapeutic options for the treatment of tricuspid regurgitation] 18
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 18
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 17
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 17
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 17
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 17
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 16
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 16
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 16
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 16
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 15
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 15
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 15
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 15
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 15
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 15
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 15
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 14
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 14
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 14
Contrast-induced kidney injury: how does it affect long-term cardiac mortality? 14
[40 Years of coronary angioplasty: success comes from skills and determination!] 14
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 14
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 14
Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future 14
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 14
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 14
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve replacement: incidence, time course and predictive factors 14
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 13
Outcomes in coronary stents trials - 1 year is not enough 13
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 13
Left atrial appendage closure: A single center experience and comparison of two contemporary devices 13
Advances in percutaneous interventional therapies: The tricuspid valve 13
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 13
Clinical and anatomical predictors of mitraclip therapy failure for functional mitral regurgitation. 13
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 13
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 13
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 12
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 12
FEVER AFTER TAVI (TRANSCATHETER AORTIC VALVE IMPLANTATION): IS IT INFLAMMATION OR INFECTION? 12
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 12
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media 12
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 12
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 12
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 12
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 12
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 11
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 11
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 11
Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further 11
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 11
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 11
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 11
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study 11
Percutaneous treatment of an iatrogenic aorta-to-right atrium fistula 11
Radiation exposure and contrast agent reduction during transcatheter aortic valve implantation: An ongoing experience 11
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 11
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 11
Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis 11
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 11
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 11
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 10
A new tool for the forgotten valve: a score to predict the risk of surgery 10
Use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures 10
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 10
Transfemoral Implantation of a Balloon-Expandable Transcatheter Valve in a Rigid Mitral Annuloplasty Ring Optimized by Post-Dilatation 10
The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation 10
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 10
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 10
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 10
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 10
Relationship between Syntax Score and prognostic localization of coronary artery lesions with conventional risk factors, plasma profile markers, and carotid atherosclerosis (CAPP Study 2) 10
Effects of drug-eluting stents after rotational atherectomy: Evidence from a multicenter experience 10
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 10
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 9
Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement 9
Echocardiographic 'brainstorm' to detect anomalous origin of the left coronary artery from the pulmonary artery 9
Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure 9
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 9
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 9
Bioresorbable Vascular Scaffolds for the Treatment of Chronic Total Occlusions: An International Multicenter Registry 9
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 9
Totale 1.399
Categoria #
all - tutte 36.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 3 0 0 5 2 0 0 0 0 0 0 0
2020/202128 0 0 1 8 1 13 0 0 2 1 1 1
2021/202299 5 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024444 19 32 53 59 37 50 13 41 5 10 21 104
2024/2025376 376 0 0 0 0 0 0 0 0 0 0 0
Totale 2.144